CHRONIC GRAFT VS. HOST DISEASE
Clinical trials for CHRONIC GRAFT VS. HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VS. HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VS. HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients whose bodies fight back
Disease control Recruiting nowThis study is testing the drug ruxolitinib in Chinese adults and adolescents (aged 12+) who have chronic graft-versus-host disease (cGvHD) that does not improve with standard steroid treatment. The goal is to see if ruxolitinib can help control the disease and reduce symptoms. Ab…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Experimental drug offered to one patient fighting transplant complications
Disease control AVAILABLEThis is an expanded access program that allows one patient with chronic graft-versus-host disease (GVHD) to receive the investigational drug axatilimab outside of a formal clinical trial. The program requires special approvals from the company, ethics committees, and regulatory a…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Sponsor: Incyte Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Major study aims to unlock secrets of serious transplant complication
Knowledge-focused Recruiting nowThis study aims to learn more about chronic graft-versus-host disease (cGVHD), a serious and complex condition that can occur after a stem cell transplant. Researchers will observe about 650 patients, including some who have had transplants but do not have cGVHD, to identify mark…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC